Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey - PubMed (original) (raw)
Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey
Adit A Ginde et al. Arch Intern Med. 2009.
Abstract
Background: Recent studies suggest a role for vitamin D in innate immunity, including the prevention of respiratory tract infections (RTIs). We hypothesize that serum 25-hydroxyvitamin D (25[OH]D) levels are inversely associated with self-reported recent upper RTI (URTI).
Methods: We performed a secondary analysis of the Third National Health and Nutrition Examination Survey, a probability survey of the US population conducted between 1988 and 1994. We examined the association between 25(OH)D level and recent URTI in 18 883 participants 12 years and older. The analysis adjusted for demographics and clinical factors (season, body mass index, smoking history, asthma, and chronic obstructive pulmonary disease).
Results: The median serum 25(OH)D level was 29 ng/mL (to convert to nanomoles per liter, multiply by 2.496) (interquartile range, 21-37 ng/mL), and 19% (95% confidence interval [CI], 18%-20%) of participants reported a recent URTI. Recent URTI was reported by 24% of participants with 25(OH)D levels less than 10 ng/mL, by 20% with levels of 10 to less than 30 ng/mL, and by 17% with levels of 30 ng/mL or more (P < .001). Even after adjusting for demographic and clinical characteristics, lower 25(OH)D levels were independently associated with recent URTI (compared with 25[OH]D levels of > or =30 ng/mL: odds ratio [OR], 1.36; 95% CI, 1.01-1.84 for <10 ng/mL and 1.24; 1.07-1.43 for 10 to <30 ng/mL). The association between 25(OH)D level and URTI seemed to be stronger in individuals with asthma and chronic obstructive pulmonary disease (OR, 5.67 and 2.26, respectively).
Conclusions: Serum 25(OH)D levels are inversely associated with recent URTI. This association may be stronger in those with respiratory tract diseases. Randomized controlled trials are warranted to explore the effects of vitamin D supplementation on RTI.
Figures
Figure
Participants with recent upper respiratory tract infection (URTI) stratified by serum 25-hydroxyvitamin D level (to convert to nanomoles per liter, multiply by 2.496) and season. Error bars represent standard errors of estimates.
Comment in
- Vitamin D level, respiratory tract infections, and controlled trials.
Hemilä H. Hemilä H. Arch Intern Med. 2009 Aug 10;169(15):1443; author reply 1443-4. doi: 10.1001/archinternmed.2009.246. Arch Intern Med. 2009. PMID: 19667312 No abstract available.
Similar articles
- Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey.
Quraishi SA, Bittner EA, Christopher KB, Camargo CA Jr. Quraishi SA, et al. PLoS One. 2013 Nov 15;8(11):e81120. doi: 10.1371/journal.pone.0081120. eCollection 2013. PLoS One. 2013. PMID: 24260547 Free PMC article. - Vitamin D status and acute respiratory infection: cross sectional results from the United States National Health and Nutrition Examination Survey, 2001-2006.
Monlezun DJ, Bittner EA, Christopher KB, Camargo CA, Quraishi SA. Monlezun DJ, et al. Nutrients. 2015 Mar 13;7(3):1933-44. doi: 10.3390/nu7031933. Nutrients. 2015. PMID: 25781219 Free PMC article. - 25-hydroxyvitamin D levels and the risk of mortality in the general population.
Melamed ML, Michos ED, Post W, Astor B. Melamed ML, et al. Arch Intern Med. 2008 Aug 11;168(15):1629-37. doi: 10.1001/archinte.168.15.1629. Arch Intern Med. 2008. PMID: 18695076 Free PMC article. - Prenatal vitamin D status and respiratory and allergic outcomes in childhood: A meta-analysis of observational studies.
Pacheco-González RM, García-Marcos L, Morales E. Pacheco-González RM, et al. Pediatr Allergy Immunol. 2018 May;29(3):243-253. doi: 10.1111/pai.12876. Epub 2018 Mar 8. Pediatr Allergy Immunol. 2018. PMID: 29444346 Review. - Vitamin D and respiratory tract infections in childhood.
Esposito S, Lelii M. Esposito S, et al. BMC Infect Dis. 2015 Oct 28;15:487. doi: 10.1186/s12879-015-1196-1. BMC Infect Dis. 2015. PMID: 26521023 Free PMC article. Review.
Cited by
- Vitamin D for the management of chronic obstructive pulmonary disease.
Williamson A, Martineau AR, Jolliffe D, Sheikh A, Janssens W, Sluyter J, Rafiq R, de Jongh R, Griffiths CJ. Williamson A, et al. Cochrane Database Syst Rev. 2024 Sep 27;9(9):CD013284. doi: 10.1002/14651858.CD013284.pub2. Cochrane Database Syst Rev. 2024. PMID: 39329240 Review. - Role of vitamin D in COVID-19 and other viral infections.
Engin MMN, Özdemir Ö. Engin MMN, et al. World J Virol. 2024 Sep 25;13(3):95349. doi: 10.5501/wjv.v13.i3.95349. World J Virol. 2024. PMID: 39323448 Free PMC article. Review. - Is Micronutrient Supplementation Helpful in Supporting the Immune System during Prolonged, High-Intensity Physical Training?
Felice F, Moschini R, Cappiello M, Sardelli G, Mosca R, Piazza L, Balestri F. Felice F, et al. Nutrients. 2024 Sep 5;16(17):3008. doi: 10.3390/nu16173008. Nutrients. 2024. PMID: 39275323 Free PMC article. Review. - Effectiveness of Vitamin D and Alpha-Lipoic Acid in COVID-19 Infection: A Literature Review.
Nguyen M, Aulick S, Kennedy C. Nguyen M, et al. Cureus. 2024 Apr 27;16(4):e59153. doi: 10.7759/cureus.59153. eCollection 2024 Apr. Cureus. 2024. PMID: 38803740 Free PMC article. Review. - Vitamin D regulates COVID-19 associated severity by suppressing the NLRP3 inflammasome pathway.
Khalil B, Sharif-Askari NS, Hafezi S, Sharif-Askari FS, Al Anouti F, Hamid Q, Halwani R. Khalil B, et al. PLoS One. 2024 May 15;19(5):e0302818. doi: 10.1371/journal.pone.0302818. eCollection 2024. PLoS One. 2024. PMID: 38748756 Free PMC article.
References
- Burt CW, McCaig LF, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2005. Adv Data. 2007;388:1–15. - PubMed
- Monto AS. Epidemiology of viral respiratory infections. Am J Med. 2002;112(suppl 6A):4S–12S. - PubMed
- Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163(4):487–494. - PubMed
- Bramley TJ, Lerner D, Sarnes M. Productivity losses related to the common cold. J Occup Environ Med. 2002;44(9):822–829. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical